Middle East & Africa Embolization Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The embolization devices market in the Middle East and Africa is projected to grow significantly, reaching an estimated US$ 162.93 million by 2031, up from US$ 93.26 million in 2024. This growth represents a compound annual growth rate (CAGR) of 8.3% from 2025 to 2031.

Executive Summary and Market Analysis

The market is divided into key regions: the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The growth of this market is driven by several factors, including advancements in technology and the efforts of market players. Additionally, improvements in healthcare infrastructure, a rising incidence of chronic diseases, supportive government initiatives, and strategic actions by companies are contributing to the expansion of the embolization devices market in the region. The integration of modern technologies is also a significant factor in this growth. Countries like the UAE and Saudi Arabia are witnessing increased healthcare investments and infrastructure development, which facilitate the adoption of advanced medical technologies, leading to enhanced healthcare facilities and a more skilled workforce, thereby increasing the demand for embolization devices.

Market Segmentation Analysis

The Middle East and Africa embolization devices market can be segmented by type, application, and end user:

By Type: The market includes embolization coils, plugs, beads, glues, and other devices. In 2024, embolization coils held the largest market share, with further segmentation into central and peripheral applications.
By Application: The applications of embolization devices are categorized into neurology, peripheral vascular disease, oncology, urology, and others. Neurology was the leading application segment in 2024.
By End User: The end users of these devices include hospitals, ambulatory centers, and others, with hospitals accounting for the largest share in 2024.

Market Outlook

The prevalence of vascular diseases, such as peripheral artery disease (PAD), aneurysms, and arteriovenous malformations (AVMs), is increasing globally, particularly among older adults and those with lifestyle-related risk factors. Peripheral vascular disease encompasses both PAD and venous diseases. Annually, approximately 500,000 deaths occur worldwide due to brain aneurysms, which are most common in individuals aged 35 to 60, with a significant number developing after age 40. Ruptured brain aneurysms contribute to 3-5% of all new strokes.

Postpartum hemorrhage is a leading cause of maternal mortality, affecting around 14 million women each year and resulting in approximately 70,000 deaths globally. Furthermore, the prevalence of uterine fibroids has surged by nearly 79% over the past 30 years, from 126.41 million to 226.05 million cases. Embolization devices are effective in treating these conditions by blocking abnormal blood flow in vessels, making them a preferred option due to their minimally invasive nature. This technique is particularly useful for managing severe bleeding after childbirth and for treating fibroids, leading to symptom relief.

Country Insights

The market is further analyzed by country, with Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa being the primary regions. South Africa held the largest market share in 2024. The Saudi government’s Vision 2030 initiative aims to enhance the healthcare sector by increasing private sector involvement and investing in medical infrastructure. For example, the Ministry of Health in Saudi Arabia announced plans in 2019 to build several new hospitals. Additionally, the Gulf Cooperation Council (GCC) has committed to investing US$ 66.67 billion (SR 250 billion) in healthcare infrastructure, aiming to increase private sector participation from 40% to 65% by 2030. These initiatives are expected to strengthen the healthcare system and promote the adoption of advanced medical devices, including embolization technologies.

Company Profiles

Key players in the embolization devices market include Medtronic Plc, Cook Medical Holdings LLC, Stryker Corp, Boston Scientific Corp, Terumo Corp, Johnson & Johnson, Abbott Laboratories, NeuroSafe Medical Co. Ltd, Wallaby Medical, Sirtex Medical Ltd, GEM srl, Penumbra Inc., Balt, Lepu Medical Technology Beijing Co Ltd, INVAMED, Meril Life Sciences Pvt Ltd, Merit Medical Systems Inc, and Lifetech Scientific Corp. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their product offerings and increase market share.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa embolization devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa embolization devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the embolization devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. Show more